Product logins

Find logins to all Clarivate products below.


Dialysis Access Treatment Devices | Market Insights | Japan | 2019

Dialysis access treatment trends differ significantly in Japan compared to those in other regions, with physicians choosing short AVF maturation times and strongly favoring hemodialysis over other treatments typically used for ESRD. However, the Japanese market continues to face a number of impediments, including biennial reimbursement cuts and more limited device availability.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for dialysis access treatment products in Japan across a 10-year period.

Related Medtech Insights Reports

Report
Cardiac Rhythm Management Devices – Market Insights – United States
The US CRM device market is projected to grow slightly through 2035, driven by the increasing adoption of innovative devices, particularly extravascular ICDs, and CSP-capable pacing and…
Report
Neurovascular Devices – Market Insights – Asia Pacific
The Asia Pacific neurovascular device market will grow moderately through the forecast period, driven by rising procedure volumes, anticipated product launches, and increasing affordability of…
Report
Deep Venous Disease Treatment Devices – Market Insights – Global
The uptake of innovative, higher-priced powered thrombectomy devices and their increasing adoption for treating PE—supported by favorable clinical data—will drive strong growth in the global…
Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2035 because demand for MIS procedures will rise in line with the country’s rapidly aging population. The adoption of…